Inserm Company Profile

03:47 EDT 25th September 2018 | BioPortfolio



101 rue de Tolbiac


Phone: 33 (0)1 44 23 60 00
Fax: 33 (0)1 45 85 68 56

News Articles [34 Associated News Articles listed on BioPortfolio]

[Editorial] France may be back, but the old ways persist for INSERM

On June 12, the term of the Chief Executive Officer (CEO) of the French National Institute of Health and Medical Research (INSERM) ends. The office of the current CEO, Yves Lévy, came under heavy cri...

Zika: An accurate estimation of the neurological risks in unborn children

(INSERM (Institut national de la santé et de la recherche médicale)) Thanks to a study conducted in pregnant women and their unborn children during the Zika epidemic in the French territories in the...

Immunoscore: A test to improve the care and treatment of colon cancer

(INSERM (Institut national de la santé et de la recherche médicale)) With Immunoscore, a test devised by a team of researchers from Inserm and Université Paris Descartes and doctors from the Paris ...

CLOVES Syndrome: Remarkable improvement in the health of 19 patients medical first

(INSERM (Institut national de la santé et de la recherche médicale)) Dr Guillaume Canaud at the Necker-Enfants Malades Hospital AP-HP, the Paris Descartes University, Inserm and his team recently d...

The nature of the Ebola virus responsible for the 9th epidemic currently raging in the DRC character

(INSERM (Institut national de la santé et de la recherche médicale)) The National Institute for Biomedical Research (INRB) of Kinshasa and Inserm have characterized the nature of the Ebola virus res...

Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership

MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company fo...

Telix, INSERM, and ARRONAX Enter Agreement

To explore the feasibility of using several of Telix's clinical targeting agents with astatine

Seeing the Unexpected: Regulatory T Cells and Basophils

Dr. Jagadeesh Bayry from INSERM discusses his recent research in the field of immunology, and how T regulatory cells activate, rather than suppress, basophils.

Drugs and Medications [0 Results]


Clinical Trials [25 Associated Clinical Trials listed on BioPortfolio]

Immunological Consequences of CARD15/NOD2 Mutations in Crohn's Disease

The project is based on adult and paediatric cohorts among the largest ones in Paris and located at Saint Louis and Robert Debré hospitals. Experiments will be performed at INSERM Unit U8...

Search for New Genetic Mutations Major Effect in Crohn's Disease

This study highlight genetics mutations with major effect in Crohn's Disease (CD) by WES in individuals affected and healthy individuals from EPIMAD Inserm InVS registry families.

Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus Markers

The aim of this study is to validate in the context of liver transplantation, the interest of the cccDNA assay technique developed by the team of Professor Zoulim (INSERM U1052) on liver b...

Searching Biomarkers of Acute Intestinal Ischemic Injuries

The aim of the SURVIBIO study is to characterize acurate biomarkers for acute mesenteric ischemia, in particular at early stages. In the study, the development of biomarkers will be based...

Biomechanical and Ultrasonic Assessment of the Achilles Tendon in Vivo (MEDUSAA)

Among Musculoskeletal disorders (MSD) the rupture of the Achilles tendon is the most common. Up today, the mechanical and elastic properties of the Achilles tendon are still unknown, and t...

Companies [15 Associated Companies listed on BioPortfolio]

Annapurna Therapeutics and Weill Cornell Medicine

Annapurna Therapeutics, headquartered in Paris, is a privately held company dedicated to advancing gene therapy for significant unmet medical needs. It is funded by Versant Ventur...



TcLand S.A.

Founded in 2002 as a spin-off of INSERM U643/ITERT, one of the first research and transplantation centers in the world, and initially supported by the local incubator Atlanpole, TcLand is a biopharmac...


Spun off from Inserm (the French institute of health and medical research) in 2009, Sensorion is a biotech that specializes in the treatment of pathologies of the inner ear such a...

Laennec Tek

Laennec Tek is an independent CRO devoted to develop and implement innovative preclinical tests for drug discovery and safety pharmacology. The compagny was founded by Denis ESCANDE MD, PhD in februar...

More Information about "Inserm" on BioPortfolio

We have published hundreds of Inserm news stories on BioPortfolio along with dozens of Inserm Clinical Trials and PubMed Articles about Inserm for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inserm Companies in our database. You can also find out about relevant Inserm Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record